PremiumThe FlyProPhase Labs moves forward with sale of Nebula Genomics ProPhase Labs sees $50M opportunity with Crown Medical Collections ProPhase Labs reports Q1 EPS (13c) vs. (32c) last year PremiumThe FlyProPhase Labs reports FY24 EPS ($2.61) vs (98c) last year PRPH Earnings Report this Week: Is It a Buy, Ahead of Earnings? ProPhase Labs examines opportunities to leverage DTC multi-media infrastructure PremiumThe FlyProPhase Labs closes $23.6M sale of Pharmaloz Manufacturing ProPhase Labs secures private equity backing, nears lozenge deal ProPhase Labs finalizing set of cost-saving measures for non-core operations